- Home
- EIC vs ARCT Comparison
EIC vs ARCT Comparison
Compare EIC & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EIC | ARCT |
|---|---|---|
| Founded | N/A | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 228.8M | 198.1M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | EIC | ARCT |
|---|---|---|
| Price | $9.92 | $5.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 10 |
| Target Price | $12.63 | ★ $24.11 |
| AVG Volume (30 Days) | 98.5K | ★ 515.7K |
| Earning Date | 05-27-2026 | 05-07-2026 |
| Dividend Yield | ★ 13.25% | N/A |
| EPS Growth | N/A | ★ 20.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $82,031,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $12.77 |
| P/E Ratio | $9.08 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.17 | $5.77 |
| 52 Week High | $13.92 | $24.14 |
Technical Indicators
Market Signals| Indicator | EIC | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 41.92 | 31.78 |
| Support Level | $9.83 | N/A |
| Resistance Level | $10.15 | $7.98 |
| Average True Range (ATR) | 0.19 | 0.44 |
| MACD | -0.02 | -0.09 |
| Stochastic Oscillator | 21.19 | 5.98 |
Price Performance
Historical ComparisonAbout EIC Eagle Point Income Company Inc.
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.